Clinical Trials Browser

Phase 2 × Mitoxantrone × Plasma cell × Clear all

NCT00005987 2017-11-29

Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Alfa in Treating Patients With Multiple Myeloma

Phase 2 Terminated

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00100477 2013-09-25

Use of Topotecan in Patients With Refractory Acute Leukemia

Phase 2 Completed

LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma